AU2001258836A1 - Preventives and remedies for pulmonary hypertension - Google Patents
Preventives and remedies for pulmonary hypertensionInfo
- Publication number
- AU2001258836A1 AU2001258836A1 AU2001258836A AU5883601A AU2001258836A1 AU 2001258836 A1 AU2001258836 A1 AU 2001258836A1 AU 2001258836 A AU2001258836 A AU 2001258836A AU 5883601 A AU5883601 A AU 5883601A AU 2001258836 A1 AU2001258836 A1 AU 2001258836A1
- Authority
- AU
- Australia
- Prior art keywords
- preventives
- remedies
- pulmonary hypertension
- hypertension
- pulmonary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/195—Chemokines, e.g. RANTES
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000161145 | 2000-05-26 | ||
JP2000-161145 | 2000-05-26 | ||
PCT/JP2001/004381 WO2001089582A1 (en) | 2000-05-26 | 2001-05-25 | Preventives and remedies for pulmonary hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001258836A1 true AU2001258836A1 (en) | 2001-12-03 |
Family
ID=18665218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001258836A Abandoned AU2001258836A1 (en) | 2000-05-26 | 2001-05-25 | Preventives and remedies for pulmonary hypertension |
Country Status (3)
Country | Link |
---|---|
US (1) | US7309693B2 (en) |
AU (1) | AU2001258836A1 (en) |
WO (1) | WO2001089582A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1461300B1 (en) | 2001-11-30 | 2011-07-27 | Biogen Idec MA Inc. | Antibodies against monocyte chemotactic proteins |
EP1538207B1 (en) | 2002-09-12 | 2010-06-02 | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute | Human anti-human mcp-1 antibody and antibody fragment thereof |
EP1596926A2 (en) | 2003-02-07 | 2005-11-23 | The Johns Hopkins University | Hypoxia induced mitogenic factor |
CA2544924A1 (en) * | 2003-11-05 | 2005-05-19 | Centocor, Inc. | Methods and compositions for treating mcp-1 related pathologies |
MX2008002101A (en) * | 2005-08-12 | 2008-04-19 | Schering Corp | Mcp1 fusions. |
US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
EP2042516A1 (en) * | 2007-09-27 | 2009-04-01 | Protaffin Biotechnologie AG | Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same |
ES2533493T3 (en) * | 2008-08-20 | 2015-04-10 | Probiodrug Ag | Antibodies directed against 1 monocyte chemoattractant protein (MCP-1 N1pE) from pyroglutamate |
JP2012516143A (en) * | 2009-01-30 | 2012-07-19 | プロットアフィン ビオテヒノロギー アクチエンゲゼルシャフト | MCP-1 mutants that antagonize glycosaminoglycans and methods of use thereof |
US8524217B2 (en) | 2010-05-11 | 2013-09-03 | Merck Sharp & Dohme Corp. | MCP1-Ig fusion variants |
EP3096776B1 (en) | 2014-01-22 | 2020-12-02 | Antagonis Biotherapeutics GmbH | Novel glycosaminoglycan-antagonising fusion proteins and methods of using same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459128A (en) | 1993-11-12 | 1995-10-17 | Dana-Farber Cancer Institute | Human monocyte chemoattractant protein-1 (MCP-1) derivatives |
US5739103A (en) | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
CA2198988A1 (en) * | 1997-03-03 | 1998-09-03 | Mai Nguyen | P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
US6133502A (en) * | 1997-03-10 | 2000-10-17 | Takeda Chemical Industries, Ltd. | Monocyte chemoattractant protein and its receptor transgenic animal |
EP0887081B1 (en) * | 1997-06-27 | 2003-04-23 | Smithkline Beecham Corporation | Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy |
JPH1149700A (en) * | 1997-07-31 | 1999-02-23 | Toray Ind Inc | Therapeutic agent for pulmonary disease |
CN1279668A (en) * | 1997-11-18 | 2001-01-10 | 帝人株式会社 | Cyclic amine derivatives and their use as drugs |
JP2000161145A (en) * | 1998-12-02 | 2000-06-13 | Isuzu Motors Ltd | Fuel injection control device for multiple cylinder engine |
US20040185450A1 (en) * | 2003-03-21 | 2004-09-23 | Heavner George A. | MCP-1 mutant proteins, antibodies, compositions, methods and uses |
CA2544924A1 (en) * | 2003-11-05 | 2005-05-19 | Centocor, Inc. | Methods and compositions for treating mcp-1 related pathologies |
-
2001
- 2001-05-25 US US10/276,971 patent/US7309693B2/en not_active Expired - Fee Related
- 2001-05-25 AU AU2001258836A patent/AU2001258836A1/en not_active Abandoned
- 2001-05-25 WO PCT/JP2001/004381 patent/WO2001089582A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20030162737A1 (en) | 2003-08-28 |
WO2001089582A1 (en) | 2001-11-29 |
US7309693B2 (en) | 2007-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU2001251136A1 (en) | Compositions and methods for promoting wound healing | |
AU2001261490A1 (en) | Paper sizing compositions and methods | |
AU2001239937A1 (en) | High bulk tissue web | |
AU2002248232A1 (en) | Spiral couplers | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2001248742A1 (en) | Compositions for promoting sleep | |
AU2002215116A1 (en) | Expander | |
AU2002224866A1 (en) | Homocinetic fixed joint | |
AU2001292864A1 (en) | Methods and compositions for modulating angiogenesis | |
AU2001234782A1 (en) | Compositions and methods for promoting healthy joints | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001249855A1 (en) | Aqueous mineral compositions and methods for their use | |
AU2001295321A1 (en) | Expansion joint | |
AU2002210925A1 (en) | Preventives/remedies for portal hypertension | |
AU2001258836A1 (en) | Preventives and remedies for pulmonary hypertension | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2002222676A1 (en) | Preventives or remedies for endometriosis | |
AU2001232271A1 (en) | Preventives/remedies for postoperative stress | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU2001233086A1 (en) | Ceramidase compositions and methods based thereon | |
AU2001275667A1 (en) | Homocinetic joint | |
AU2002214681A1 (en) | Hypertension | |
AU2002349411A1 (en) | Remedies for primary pulmonary hypertension | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof |